Buzz Pocket

Monday, March 15, 2021

Healthcare Gamification Market Is Projected to Grow at a Substantial Rate by 2027

the healthcare gamification market share is predicted to grow at a cagr of 11.9% by generating a revenue of $47,281.5 million by 2026.

Gamification includes applying the techniques used in game, mechanics of game, and game style in non-gaming applications to engage the audience and make the dull task into more fun and engaging. Basically it is an application of elements in video games, which helps to solve the everyday problem and enables the user to change the behavior, develop skills and enable innovation in health care. The goal of the gamification is to change the behavior of the patient. The increase in the wearables and health & wellness app with gamification is the strong sign that the people are liking it.

The increase in the usage of digitalization and the technology adoption are expected to drive the healthcare gamification market. Many companies are using the digital platform for the people to check their health data. For instance, Pokémon go helped the players to increase the step count of the user, consciously or unconsciously which helps in making them fit without knowing them. By the use of such application, it provides offers and rewards to keep self-motivated and keep a check on their health. So, digitalization and adoption of such technologies is predicted to upsurge the market.

Improper use of these games and training programs is considered to be the biggest restrains for market. These gamifications are programmed in such a way that it can help to attain the objective. But these gamifications are used only for fun purpose and once the desire is being fulfilled then they lose interest on these devices and applications which can hamper the growth of the market in the forecast year.

Casual game is held the largest market share of 42% in the type segment. Causal game is forecasted to grow at a CAGR of 10.2 by generating a revenue of $17,541.5 million by 2026. Casual games are usually build to monitor the user’s behavior and provide necessary therapy.

Prevention accounted for the highest growth rate in the application segment. Rise in the fitness enthusiast with the availability of several app and devices is expected to drive the market for prevention. Prevention application was $4,231.3 million in 2018 and is anticipated to generate a revenue of $11,584.0 million by 2026.

Depending on the end use the market is segmented into consumer based and enterprise based. Enterprise based accounted for the highest growth rate of 15.7% over the forecast period, at $5,577.6 million in 2018. Due to the various benefits offered by the employer the employees are the participation in gamification events has grown considerably in the recent years.

Depending on the region the market is segmented into Asia-Pacific, North America, Europe and LAMEA. Asia Pacific accounted for the highest market share of 32.0% in 2018. Asia pacific is predicted to grow at a CAGR of 11.0% by generating a revenue of $14,184.5 million by 2026. Due to the rise in the population and lesser medical facilities is expected to drive the market for this region.

Key competitors in the market are Mango Health, JawBone, Nike, Hubbub Health, EveryMove, Akili Interactive labs, Bunchball, Microsoft, Ayogo Health, and Fitbit among others. Mango health have developed a new gaming application which rewards patients with points every time they set reminder alerts for the medicine consumption.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Antiviral Therapies Market 2020 to Witness Excellent Long-Term Growth Outlook

Post COVID-19 Impact on Antiviral Therapies Market –

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following:
• Long-term and short-term impact of Covid-19 on the market
• Cascading impact of Covid-19 on Antiviral Therapies Market, due to the impact on its extended ecosystem
• Understanding the market behavior Pre- and Post-COVID-19 pandemic
• Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity
• We’ll help you fight this crisis through our business intelligence solutions.

Pre COVID-19 Analysis of Antiviral Therapies Market –

global antiviral therapy market size is expected to grow with a cagr of 5.8% from 2019 to 2026 according to a study conducted by research dive. the global antiviral therapy market size was accounted at $48.1 billion in 2018 and is anticipated to garner $ 75.6 billion by 2026.

Increasing incidences of viral infections, growing awareness among public about these infections, rise in healthcare spending, growing R&D investments, and growing incidences of severe and deadly disorders in people are the key antiviral therapy market drivers responsible to boost the growth of global market during estimated period. In addition, development of broad-spectrum antibiotics and surge in profitable opportunities in the developing economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities for the growth of the market. On the other hand, huge costs involved in the manufacturing of these therapy and rise in the demand for alternative medicines such as homeopathy and naturopathy are expected to restrain the development of the market.

The HIV segment in the antiviral therapy market was valued at $16.4 billion in the year 2018 and is expected to increase with a growth rate of 5.4% throughout the estimated period. This is because of the rising occurrence of HIV infection across the globe. The majority of HIV antiviral drug usage has been seen in the North America region. Also, the consumption of antiviral therapy in African region is expected to increase and fuel the development of the market.

The online pharmacy segment is expected to grow at an increased speed by generating a revenue of $23.2 billion by the end of 2026, at a significant growth rate of 6.1% during the forecast period. On the other hand, the hospital pharmacy segment is anticipated to dominate the market by generating a revenue of $35.5 billion by the end of 2026, at a substantial growth rate of 5.5% throughout the forecast period. This is mainly due growing trends in the online shopping sector in the developed and developing countries. At present, the market share is mainly controlled by a few top pharmaceuticals as well as biotechnology companies.

Regionally, the market has been studied across Asia-Pacific, North America, Europe, and LAMEA. Asia-Pacific antiviral therapy market is anticipated to grow at an increased pace with a healthy growth rate of 6.5% during the forecast period, garnering $12.8 billion by the end of 2026. This is mainly due to factors such as the growing cases of HIV infection, growing awareness about HIV infection, and increasing collaboration between public and private sectors in this region. Furthermore, the North America antiviral therapy market held a leading position in the global antiviral therapy market in 2018. This region is anticipated to hold its lead position in the market throughout the forecast period by generating a revenue of $29.5 billion by 2026. This is attributed to factors such as the rising occurrence of HIV and hepatitis C infections, well-established market players in the region, growing healthcare awareness, rising elderly population, and increasing healthcare spending in this region. On the contrary, factors such as patent expiration and generic erosion of antiviral therapy are hindering the growth of the market in this region.

View out Trending Reports with the Impact of COVID-19: https://www.researchdive.com/covid-19-insights

The key market players profiled in the report are F. Hoffmann-La Roche Ltd., Gilead Sciences, GlaxoSmithKline, Abbott Laboratories, AbbVie Inc., AstraZeneca Plc., Bristol- Myers-Squibb, Johnson & Johnson, Schering-Plough Corporation, and Merck & Co., Inc. These market players are undertaking several activities to grab a major share of the market and hold a leading position in the antiviral therapies industry. Some of these activities include new product launches, mergers and acquisitions, antiviral therapy market developments in current technology. These are some of the growth strategies implemented by these market players.

Contact Us:

3D Cell Culture Market Is Expected To Grow with a Healthy CAGR During 2020-2027

Post COVID-19 Impact on 3D Cell Culture Market –

Our study helps to acquire the following:
• Long-term and short-term impact of Covid-19 on the market
• Cascading impact of Covid-19 on 3D Cell Culture Market, due to the impact on its extended ecosystem
• Understanding the market behavior Pre- and Post-COVID-19 pandemic
• Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity
• We’ll help you fight this crisis through our business intelligence solutions.

Pre COVID-19 Analysis of 3D Cell Culture Market –

according to a study of research dive, global 3d cell culture market forecast shall cross $12,638.8 million by 2026, growing at a cagr of 29.4 during forecast period.

3D Cell culture is an essential tool in clinical analysis and biological science. It has multiple applications such as in biosensors, drug screening and others. Many improvements have been made in automated high-throughput cell culture systems. Increasing demand for regenerative medicine and economic drug discovery is expected to drive the demand for the 3D cell culture market. 3D cell cultures are primarily used to observe the abnormal behavior of cells and the cell-cell interaction. Furthermore, 3D cell culture systems play a significant role in the development of precision medicine and personalized medicine. For instance, as per study of cancer researchers (University of Michigan) newly invented 3D structure could enable physicians to test medications on model tumors grown from a patient’s own cells. These advances are projected to boost the growth of global cell culture market. However, more complex culture system, added expenses and threats from substitutes like 2D cell cultures are projected to limit the 3D cell culture market growth.

With new advances, 3D composite scaffolds have many versatile properties. It will be tremendously useful to develop treatments for nerve disorders and spinal cord injury (SCI) by taking help of cell transplantation methodologies and biomaterials. The most remarkable advantage of 3D cell culture is, their properties can be easily adapted by modifying the structure and composition. These key factors of 3D cell culture are projected to create enormous opportunities for the growth of 3D cell culture industry.

According to Analyst Evaluation, Microchips market shall register a revenue of $2,515.5 million by the end of 2026, growing at a CAGR of 30.1% during the forecast period; this is significantly due to new advances in 3D culture ‘organs-on-chips’. Organs-on-chips allow study of human physiology and also reveal development of novel in vitro disease models. It could provide potential replacements for animals used in toxin testing and drug development. These advancements are anticipated to grow the demand of microchips in global market, and are projected to boost the global market. Scaffold-based platforms have the largest market share and this segment will register a revenue of $3,425.1 million by the end of 2026, growing at a CAGR of 28.4%. Scaffolds can be significantly used in drug development therapeutic or specialty areas; which is anticipated to fuel the of global market growth.

Based on applications, the market is segmented into Stem Cell research, drug discovery, cancer research, and regenerative medicine. 3D cell culture market size for cancer research will generate a revenue of $4,057.1 million by 2026, growing at a CAGR of 28.5% throughout the forecast period; this is majorly due to various types of cancers such as breast cancer, lung cancer and others being dominant among the population. Cancer has a pervasive prevalence across the globe, which has led to rise in demand for cancer research, which is further attributed to boost the demand for 3D cell culture market. 3D cell culture market for regenerative medicine will register a revenue of $3,690.5 million by 2026, growing at a CAGR of 30.1%. Many developed and developing countries such as Japan is focusing more on contract manufacturing tie-ups, and continues to be a lucrative place for biotech ventures to do business. Japan is the world leader in regenerative medical products; these key strategies of the government are anticipated to spur the growth of 3D cell culture market.

3D cell culture market for biotechnology & pharmaceutical companies will register a revenue of $5,184.4 million by 2026, growing at a CAGR of 28.9% during the forecast period; this is majorly due to huge developments in the laboratory, technology and operations. Furthermore, rising pressure on sales of established treatments, rapid growth of cell therapies and focus on advanced manufacturing and technologies are the factors expected to grow the market.

North America 3D Cell Culture market size will cross $4,019.1 million by 2026, increasing at a healthy CAGR of 28.1%.

Heavy investments in research & development, high healthcare expenditure, and extensively increasing number of cancer cases are considered to be one of the driving factors that are booming the growth of North American market.

3D Cell Culture market share for Asia-Pacific region is expected to rise at a CAGR of 30.7% by generating a revenue of $3,020.7 million by 2026. The market growth in the region is increasing drug discovery initiatives among pharmaceuticals and biotechnology companies in the region. Major economies such as India, Singapore, Japan and South Korea are emphasizing more on public sector openness to partnership with established companies. For instance, leading market players such as Bayer, GlaxoSmithKline and AstraZeneca are collaborating with Singapore partners across drug discovery.

View out Trending Reports with the Impact of COVID-19: https://www.researchdive.com/covid-19-insights

The major 3D Cell Culture manufacturers include QGel SA, Hµrel Corporation, SynVivo, Greiner Bio-One International, Advanced BioMatrix, Lonza, Corning Incorporated, Thermo Fisher Scientific, TissUse GmbH, 3D Biotek. Players using updated technologies for their 3D Cell Culture will have good probability of having success in the rapidly blooming market. For example, Lonza has innovated the RAFT 3D Culture System that produces hepatocytes with increased stability and stronger cytochrome responses.

Contact Us:

Medical Tourism Market Anticipated for Progressive CAGR Growth During 2020-2027

Traveling to overseas for affordable and state-of-the-art medical care and treatment is basically termed as medical tourism. Years back, people from developing countries used to travel to highly developed countries seeking advanced and safer treatment, which was barely available in their own countries. Today, people from developed countries travel to developing countries for cost-effective medical treatments, which has slightly changed the traditional concept of medical tourism.

the medical tourism market share is predicted to rise at a cagr of 12.4% and is expected to reach $149.34 million till 2026. earlier, in 2018, market was valued $58.62 billion.

Medical tourism means when a person travels to the other country to undergo a treatment. This is usually done by the patient when the medication is more expensive in their respective country or due to the unavailability of advanced medication and machinery in their home country. Basically, medical tourism is the combination of medical treatment and travel at the same time. It means that one travels to another country for medical purposes spending a few days abroad and combines a vacation with the medical procedure.

The high cost of treatment in the home country and the availability of advanced medical facilities in the developing countries is predicted to drive the medical tourism market. Affordability and convenience of the good medical facilities with the guidance from the tourism department is expected to drive the medical tourism industry. For instance, in the U.S the cost spend for heart surgery will be almost 80% more than the total cost spends in Asian countries. So, due to these factors, many developed countries patients are preferring to get treated in the developing nation or the nation with high medical facilities with lesser cost for the treatment; these factors are predicted to boost the global medical tourism industry.

Private healthcare is expensive and many insurance companies don’t cover the insurance. There are many circumstances the patient has to face with regards to their insurance policy and regulation. For instance, insurance may not be covered by the company if the treatments are carried out overseas; if the insurance is covered then the insurance companies don’t pay the airfare and extra expenditures. Due to reimbursement policies, patients are forced to stay at their home country and get treated which is consider to be the major restraint for the medical tourism market.

On the basis of the service type, medical tourism market size for Cosmetic segment is projected to generate a revenue of $31,063.9 million by 2026 with a CAGR of 11.9% in the forecast period. The curiosity of people to look different and change their appearance to keep themselves confident is predicted to boost the cosmetic treatment segment in the forecast period. Cancer treatment is projected to have the highest growth rate in the estimated period. THE MEDICAL TOURISM MARKET SHARE FOR CANCER TREATMENT IS ESTIMATED TO RISE AT A CAGR OF 14.2% BY GENERATING A REVENUE OF $7,616.6 MILLION BY 2026. The rise in occurrences of cancer worldwide is estimated to boost the cancer treatment segment. The treatment of cancer takes a lot of time, and patients prefer going outside their home country for their treatment due to better medical amenities with lesser cost. Medical tourism market forecast that cancer treatment segment in medical tourism market is going to experience a boost the in the forecasted period.

Based on the region segmentation Asia-Pacific has the highest growth rate. Asia-Pacific region is estimated to rise with a CAGR of 12.2% by generating a revenue of $54,452.9 million by 2026. The Asia-Pacific region provides all the medical amenities at a reasonable price so that the patient can afford it and can be cured. Due to the tourism friendliness and government policies with regards to tourism not being that strict, patients prefer the Asia-Pacific region to get them treated. These factors will boost the medical tourism market in this region.

The major key companies in the market are Prince Court Medical Centre, Aditya Birla Memorial hospital, KPJ Healthcare Berhad, UZ Leuven, Apollo Hospitals Enterprise Ltd, Fortis Healthcare, NTT Medical Centre, Asklepios Kliniken GmbH, Bumrungrad International Hospital, KPJ Healthcare Berhad and Asian Heart Institute among others.

Contact Us:

Breast Imaging Market Expected to Witness Rapid Expansion by the End of 2027

The novel coronavirus has significantly affected the global wearable healthcare devices market in 2020. Therapeutic device segment generated for prominent market share in 2019 and strap/clip/bracelet segment held the global market share in the previous years. Also, sports & fitness segment is expected to have most lucrative throughout the forecast years and Asia-Pacific region will witness to rise at a notable rate in the coming years. The major market players are concentrating on product advancement to gain majority of the market share in the global market.

In 2020, the emergency of COVID-19 has generated a promising impact on the global wearable healthcare devices market. During the pandemic period, the novel coronavirus has put the medical devices industry at the stage of sudden demand for personal protective equipment, diagnostic testing equipment, medical supplies and ventilators. Also, increasing the importance of home healthcare application is directly impacting the demand for wearable healthcare devices due to growing awareness among the people to curb the spread of COVID-19. But, there is possibility of shortage in the supply of raw materials and transfer of finished products due to manufacturing and transportation facilities are partially stopped because of many government imposed lockdown to control the spread. These factor are significantly impacting the wearable healthcare devices market growth in the pandemic period.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/277

Moreover, many government bodies are continuously increasing initiatives to help the organizations to sustain in the pandemic period. For instance, the government of Spain has introduced new economic measures and extended unemployment benefits for people who are facing money crisis. Also, government has reduced VAT charges to 0% for the suppliers of medical equipment’s from manufacturers to non-profit organizations, hospitals and public entities as well as the VAT charges on magazines, newspapers and electronic books is also minimized. During this pandemic period, our analysts providing to market players in understanding the impact of COVID19 on the wearable healthcare devices market.

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

as per new study conducted by research dive, the global wearable healthcare devices market is expected to generate a revenue of $xx million by 2027.

The global market is classified into product, site, outlook and region. This study offers comprehensive overview about drivers, opportunities, restraints, segmental analysis and top gaining players in the global market.

• Factors affecting the market growth

As per our analysts, increasing trend for maintain fitness among the people due to growing awareness on healthy lifestyles along with continuously increasing technical advancements in the healthcare devices are projected to drive the growth of the market. But, high price associated with the instruments is expected to restrict the growth of the market.

• Therapeutic devices segment accounted for highest revenue in 2019

Based on product, the global market has been classified into diagnostic devices and therapeutic devices. In both of these, therapeutic devices accounted for significant revenue share in the previous years and is expected to rise at a notable rate throughout the estimated period. This dominance is mainly owing to extensive usage of wearable healthcare devices because the availability of therapeutic devices such as pain reliever devices, respiratory therapy devices and insulin monitoring devices.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/277

• Strap/clip/bracelet and sports & fitness segments held the global market share in previous years

Based on site, the global wearable healthcare devices market has been segmented into handheld, headband, strap/clip/bracelet, shoe sensors and others. Among these, strap/clip/bracelet segment is expected to have highest market share in the previous years and is anticipated to continue its growth with notable rate throughout the forecast years. This segment contains cloud and Bluetooth connectivity, these devices offers monitoring of several parameters including respiratory rate, heart rate and physical movement of the individuals. This factor is boosting demand for connectivity devices, which will drive the market growth in the forecast years.

Based on outlook, the global market has been categorized into sports & fitness, remote patient monitoring and home healthcare. In these, sports & fitness outlook segment generated majority of the wearable healthcare devices market share in the previous years and is expected to remain its growth in the forecast years. Growing adoption of self-monitoring devices due to availability of most cost effective connectivity devices along with increasing occurrence diseases due to unhealthy lifestyles, these factors are estimated to enhance the growth of the market in the forecast years.

• Wearable healthcare devices market, Regional analysis

The global wearable healthcare devices market has commanded by the North America in 2019 and is estimated to continue its trend throughout the forecast years. Wide utilization of healthcare devices because of increasing prevalence of cardiovascular diseases along with existence of modern healthcare facilities are boosting the growth of the market in the North America region. Also, Asia-Pacific wearable healthcare devices market will experience a remarkable growth and is estimated to produce a notable revenue in the coming years. Increasing the standards & economic conditions of the people along with existence of large manufacturing hubs in the Asia-Pacific region, these factors are favorable for the growth of the market in the coming years.

• Major market players in the global wearable healthcare devices market

The top gaining players in the global wearable healthcare devices market include edtronic plc, OMRON Corporation, Dexcom Inc., Masimo Corporation, Preventice Solutions, Inc., Fitbit, Inc., Koninklijke Philips N.V., Biotelemetry Inc., Abbott Laboratories, GE Healthcare and ten3T healthcare.

Contact Us:

Wearable Healthcare Devices Market Is Projected to Grow at a Substantial Rate by 2027 - Report by ResearchDive

The COVID-19 pandemic is anticipated to impact the global tissue diagnostics market in an optimistic way. The ISH technology segment has a higher growth rate in the forecast period. The breast cancer application segment is anticipated to show lucrative growth in the estimated period. Hospital end-user is dominating the market in terms of revenue generation. In light of the region, The North America region has generated the highest revenue in the current market situation.

The unexpected COVID-19 has changed the thought process. The COVID-19 outbreak has an optimistic impact on the global tissue diagnostic market. The rising number of cancer cases and the mortality rate is anticipated to fuel the demand of the tissue diagnostics market in the forecast period. Various developments such as 3D cell culture were developed recently that are used in the area of tissue engineering. This 3D cell culture aids in the accuracy of the study of organ physiology. Moreover, the higher cost involved in the deployment and higher penetration is expected to hamper the market growth in the forecast period. During this coronavirus crisis situation, we are helping our clients in understanding the impact of COVID-19 on the global tissue diagnostics market.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/279

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

according to a new report published by research dive, the global tissue diagnostics market is anticipated to register a revenue of $5.0 billion.

The rising number of a cancer patient’s around the globe. Moreover, technological advancements such as 3D cell culture that was developed recently that are used in the field of tissue engineering. In addition, it can be used in unique applications such as the restoration of damaged tissues. Several other technologies such as micro-engineering technologies have enhanced pharmacy research. Thus, these factors are responsible for the development of the global tissue diagnostics market in the projected period. The global tissue diagnostics market is segmented on the basis of technology, application, end-user, and region. The report provides detailed information about drivers, opportunities, restraints, segmental analysis, and competitive players of the market. As per our analysts, an increasing number of cancer patients and technological advancements are fueling the market growth in the forecast period. However, the high cost required for the deployment of systems and higher penetration is expected to hamper the market growth.

• The ISH technology segment has a higher growth rate in the forecast period

Based on the type of technology, the global tissue diagnostics market is fragmented into ISH, digital pathology, anatomy pathology, workflow, and consumables. Among these, ISH segment has the highest growth rate in the forecast period owing to the rising utilization of technology in both clinical R & D for enhancing cancer treatment. This technology also provides differentiation between types of tumors, unlike conventional methods. Thus these factors are responsible for the higher growth rate of this segment in the forecast period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/279

• Breast Cancer application segment is expected to show lucrative growth in the estimated period

On the basis of application, the global tissue diagnostics market is classified into breast cancer, prostate cancer, gastric cancer, non-small cell lung cancer, and others. Among these, the breast cancer application segment is anticipated to show lucrative growth owing to increasing breast cancer among people and inclination in the genetic inheritance.

• Hospital end-user type is dominating the market in terms of revenue generation in the forecast period

On the basis of end-user, the global tissue diagnostics market is classified into hospitals, research laboratories, pharmaceutical organizations, and research organizations. Among these, hospital end-user is dominating the market in terms of revenue generation owing to the increasing consumption of tissue diagnostics techniques in hospitals. Tissue diagnostic methods offer reduced time in the detection of health issues as compared to conventional methods.

• Regional Outlook and Major Market Players

The global tissue diagnostics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among these, the North America region has generated the highest revenue in the current condition owing to the précised medication initiative implementation in parts of the U.S.

The most prominent players in the global tissue diagnostics market are Abbott Laboratories, Danaher, Siemens, Merck KGaA, GE Healthcare, Thermo Fisher Scientific Inc., bioMérieux SA, DiaGenic ASA, QIAGEN, and others.

Contact Us:

Glycomics Market 2020 to Witness Excellent Long-Term Growth Outlook - Report by ResearchDive

The COVID-19 pandemic is anticipated to impact the global sepsis diagnostic market positively. Blood Culture Media segment will be the most profitable segment in the global market. The microbiology technology segment holds the largest market share in revenue generation. The laboratory testing type segment held significant market shares in the year 2018 and is anticipated to follow the trend until the end of the forecast period. Considering the region, the North America region holds a significant position in terms of revenue and it is predicted to grow and continue the dominance in the forecast period.

The world is facing an unexpected change and numerous industries are facing a tough situation due to the COVID-19 pandemic. The COVID-19 outbreak has positively impacted on the global sepsis diagnostic market. Sepsis is a kind of illness that is caused by a microbial pathogen, which later causes the cloning of the human pro-inflammatory cytokines and their receptors which in turn leads to inflammation. Rising awareness about the importance of testing for early detection of sepsis is the major factor for market growth. The rapid diagnostic test for the early detection of the fatal disease can be life-saver. During this coronavirus crisis, we are helping our clients in understanding the impact of COVID-19 on the global sepsis diagnostic market.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/272

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

according to a new report published by research dive, the global sepsis diagnostic market is anticipated to garner a revenue of $786.33 million by the end of the forecast period.

The global sepsis diagnostic market is bifurcated on the basis of the product, testing type, technology, and region. The report provides detailed information about drivers, opportunities, restraints, segmental analysis, and competitive players of the market. As per our analysts, rising awareness about the importance of testing for early detection of sepsis is driving the market growth in the predicted period. However, non-specific physiological and clinical tests followed by the advanced testing for the confirmation of the disease are making the test quite expensive. Thus, this is the major factor that is going to restrict the growth of the global sepsis diagnostic market in the predicted time.

• Blood Culture Product Segment will be the most profitable

Based on product, the global sepsis diagnostic market is fragmented into instruments, blood culture media, assay kits & reagents, and software. Among these, the blood culture product segment is predicted to have the highest revenue and is expected to continue its dominance in the estimated period. The segment is predicted to grow owing to its lesser cost involved and it is most widely used by physicians. Increasing demand for reagents and kits in various core regions with the rising awareness against the disease is predicted to boost the assay kits and reagents segment in the forecast period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/272

• Microbiology Technology Segment has the largest share in the revenue generation and is expected to be dominant in the forecast period

On the basis of technology, the global sepsis diagnostic market is classified into microbiology, molecular diagnostics, immunoassays, and flow cytometry. The market for the microbiology technology segment has contributed to the largest share in revenue generation and is anticipated to be dominant in the forecast period. Microbiology aids for quantitative detection and helps in identifying microorganisms by cloud culture media tests, which is expected to boost the segment in the predicted period. The diagnosis segment is anticipated to have the highest market share in the forecast period owing to the increasing use of molecular diagnostic testing due to its accuracy, turn-around time, and enhanced sensitivity.

• Laboratory Testing Segment is anticipated to become the highest revenue generator

On the basis of the testing type, the global sepsis diagnostic market is classified into laboratory testing and PoC testing. The market for laboratory testing type held a significant market share in 2018 and anticipated to become the highest revenue generator during the predicted period. An increasing number of blood culture tests conducted in laboratories is predicted to drive the laboratory testing type in the forecast period.

• Regional Outlook and Major Market Players

Global sepsis diagnostic market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among these, North America region has dominated the global market share and holds significant position in terms of revenue. The sepsis market is expected to grow in this region due to increasing healthcare expenditure and reimbursement for the diagnostic test in this region.

The most prominent players in the global sepsis diagnostic market are Dickinson and Company, Becton, Bio Merieux SA, Hoffmann-La Roche AG, Sysmex Corporation, Beckman Coulter Inc., Bruker Corporation, Thermo Fisher Scientific Inc., Cepheid Inc., and others.

Contact Us:

Tissue Diagnostics Market Is Expected To Grow with a Healthy CAGR During 2020-2027

Glycomics market is predicted to grow in terms of revenue in the forecast period. Technological advancement in the glycomics instrument is predicted to be the major driving factor for the market in the forecast period. Enzymes segment is predicted to be the most lucrative segment in the forecast period. Academic & research institutes is predicted to have highest market share in the forecast period. Asia-Pacific region market is predicted to create more investment opportunity for the investors in the forecast period.

Despite to corona pandemic, the glycomics market is predicted to grow in terms of revenue by 2027. Investment in research and development by most of the companies to treat the corona virus is predicted to be the major driving factor for the market in the forecast period. Moreover, growth of the proteomics is predicted to drive the market in the forecast period. On the other hand, increasing demand for personalized medicines is predicted to hamper the market growth in the forecast period. Moreover, high cost of glycomics tools is predicted to hamper the market growth in the forecast period. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global glycomics market.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/245

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

according to a study conducted by research dive, the glucomics market is expected to register a revenue of $2,737.9 million by 2027.

The global market is classified on the basis of product type, application, and end-use industry. The report offers the complete information about drivers, opportunities, restraints, segmental analysis and major players of the global market.

• Factors Affecting the Market Growth

As per our analyst, technological advancement in glycomics devices is predicted to be the major driving factor for the market in the forecast period. On the other hand, the expensive tools of these devices is predicted to hinder the market growth in the forecast period.

• Enzymes Segment is Predicted to be the Most Lucrative Segment

Depending on the product, the market is further segmented into enzymes, kits, reagents and instruments. Enzymes segment is predicted to have the highest market share in the forecast period. Enzymes are used in various recovery of the drugs procedures where major companies are investing in research and development is predicted to drive the segment in the forecast period.

• Drug Discovery & Development Segment is Predicted to have Maximum Growth Rate

Depending on application, the market is further segmented into drug discovery & development, diagnostics and others. Drug discovery & development is predicted to have the maximum growth rate in the forecast period. Companies investing more on developing drugs and therapies to meet the demand is predicted to drive the segment in the forecast period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/245

• Academic & Research Institutes Segment is Predicted to be the Most Profitable Segment

Depending on end user, the market is further segmented into academic & research institutes, pharmaceutical & biotechnology, companies, CROs. Academic & research institutes segment is predicted to grow enormously in the forecast period. Rapid expansion of glycomics in various field by various organization for multiple uses is predicted to boost the segment in the forecast period.

• Regional Breakdown of the Market

Depending on region, the market is further segmented into North America, Asia-Pacific, Europe and LAMEA. Asia-Pacific region market is predicted to have more growth opportunity. Increasing number of pharma companies, increase in research and development by majority of the company and increasing number of geriatric population is predicted to drive the market in the forecast period.

• Top Companies Leading the Market

The major key players in the market are The Merck Group, Agilent Technologies Inc., Thermo Fisher Scientific, New England Biolabs, Shimadzu Co., Takara Holdings, Sumitomo Bakelite Co. Ltd., Waters Co., AspariaGlycomics S.L., and Bio-Techne Co. among others.

Contact Us:

Home

Monday, March 15, 2021